Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty With 3D Shaped Rings.
1 other identifier
observational
168
1 country
1
Brief Summary
Interest in tricuspid valve disease has grown exponentially over the past few years, in response to increased interest in the poor prognosis of patients with functional tricuspid regurgitation (TR). Tricuspid valve repair (TVR) using a prosthetic ring represents the first option in many centers worldwide, due to the low incidence of residual and recurrent TR and improved survival compared to suture techniques. The goal of ring annuloplasty is to restore the normal geometry of the annulus, thereby improving the coaptation of the leaflets and preventing further dilatation of the annulus. Recently, the three-dimensional geometry of the tricuspid valve has been shown and analyzed by means of data obtained from echocardiography, CT scan and magnetic resonance imaging. Normal tricuspid annulus is characterized by a more prominent part in the anteroseptal commissure area near the aortic valve and right ventricular outflow tract and a deeper part in the posteroseptal commissure area near the coronary sinus ostium . Based on these characteristics, new three-dimensional rings have been developed for tricuspid annuloplasty, such as the MC3 (Edwards Lifescience, Irvine, CA) and the Contour 3D (Medtronic, Minneapolis, MN). There are few studies concerning the short-term results of tricuspid rings implantation and almost none on the long-term, therefore this study aims to analyze the long-term results of TVR by implantation of the two new prosthetic ring models mentioned above. The aim of this study is the long-term analysis of the results of tricuspid annuloplasty with three-dimensional rings in patients with functional IT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2020
CompletedFirst Submitted
Initial submission to the registry
January 27, 2023
CompletedFirst Posted
Study publicly available on registry
May 1, 2023
CompletedMay 1, 2023
April 1, 2023
27 days
January 27, 2023
April 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
through study completion, an average of 7 years
Interventions
A 3D ring is implanted to treat functional tricuspid valve regurgitation
Eligibility Criteria
Patients who underwent tricuspid surgery due to functional tricuspid regurgitation, treated with implant of a 3D ring
You may qualify if:
- Adult patients
- Operated for functional TR
- Implantation of three-dimensional tricuspid prosthetic ring MC3 or Contour 3D, isolated or concomitant to surgery on the left heart sections
- Surgical access in median sternotomy or minithoracotomy
You may not qualify if:
- \- emergency/urgency intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michele De Bonislead
Study Sites (1)
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief of Cardiac Surgery of Advanced and Research Therapies
Study Record Dates
First Submitted
January 27, 2023
First Posted
May 1, 2023
Study Start
December 2, 2020
Primary Completion
December 29, 2020
Study Completion
December 29, 2020
Last Updated
May 1, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share